This study builds upon a large body of evidence showing that the elevation of phosphorylated tau is not unique to Alzheimer's Disease, as pTau181 has previously been shown to be elevated in ALS. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.